Akorn ( AKRX )
Recent earnings result
- EPS beats by $0.06, revenue in-line
- Up 2% on preliminary Q3 results
Supporting docs
Events & Annual meetings
Title | Date | Webcast |
---|---|---|
Q3 2019 Akorn, Inc. Earnings Conference Call | 10/31/19 10:00 AM EDT |
webcast
|
Q2 2019 Akorn, Inc. Earnings Conference Call | 08/01/19 9:00 AM EDT | webcast |
Akorn, Inc. at Jefferies 2019 Global Healthcare Conference | 06/07/19 9:30 AM EDT | webcast |
Akorn, Inc. at 2019 RBC Capital Markets Healthcare Conference | 05/22/19 2:05 PM EDT | webcast |
Q4 2018 Akorn, Inc. Earnings Conference Call | 02/28/19 10:00 AM EST | webcast |
Disclaimer:
For more information you may also visit their official Investor Relations website.
The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.
Akorn, Inc. is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals and branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.